Ethypharm targeted in data leak claim by underground group

• Ransomware group: underground
• Country: France
• Sector: Healthcare
• Announcement date: July 1, 2024

The underground group claims a data breach at Ethypharm

The underground group has announced that data belonging to Ethypharm has been leaked. According to the announcement published on a leak site on July 1, 2024, the group claims to have compromised the company's information. The group reports that the breach or the initial attack took place on June 20, 2024.

In such cyberattack scenarios, threat actors often utilize leak sites to pressure organizations. These sites serve as a public platform where attackers post announcements regarding their successful breaches. This tactic is a central component of double extortion, a method where attackers not only encrypt an organization's data to disrupt operations but also threaten to release sensitive information publicly to increase the pressure for a ransom payment. While the ransom demand for this specific incident remains unknown, the mere presence of such an announcement indicates a significant threat to the organization's data privacy.

Details of the claimed data leak

The group has provided a screenshot as evidence of the breach, claiming that a massive volume of data has been compromised. The total size of the claimed data is approximately 875.4 GBytes. The information allegedly stolen spans multiple categories, ranging from administrative and financial documents to highly sensitive scientific and personal information.

The specific types of data claimed to be involved in the leak include:

• Sales data
• Personal files of employees
• Certificates
• Work instructions
• Agreements
• Invoices
• Accidents
• Investigations
• Legal reports
• Project finance documents
• Finance documents
• Audit reports
• Development reports and protocols
• Clinical trials and data
• Court docs
• Safety data exchange agreements
• Laboratories data
• Children's names and dob
• Business plans
• SQL Databases
• Oracle Databases

The inclusion of databases, such as SQL and Oracle, suggests that the attackers may have gained access to structured data environments, which often contain the core operational and personal information of a company.

About Ethypharm

Ethypharm is an international pharmaceutical company based in France. The company specializes in therapeutic areas such as the central nervous system and pain management. Ethypharm focuses on the development, manufacturing, and marketing of medicines aimed at improving patients' quality of life.

Potential impacts and industry implications

This alleged leak may have negative impacts on the company's operational processes and sensitive data. The nature of the leaked data may lead to legal proceedings regarding GDPR compliance, as the disclosure of personal data—including information regarding children—is a significant regulatory concern. Furthermore, the disclosure of trade secrets and sensitive business information may create opportunities for targeted phishing attacks or secondary extortion attempts against the company or its partners.

The large volume of data may also pose challenges for maintaining data integrity. For organizations operating in the healthcare and pharmaceutical sectors, such breaches are particularly critical due to the sensitive nature of clinical trials, laboratory data, and patient-related information. The loss of such data can disrupt research, development, and regulatory compliance efforts.

To defend against such threats, organizations typically implement multi-layered security strategies. This includes maintaining robust backup solutions that are isolated from the main network, implementing strict access controls to limit data exposure, and conducting regular security audits. Continuous monitoring of network traffic and employee training to recognize phishing attempts are also essential defensive steps to mitigate the risk of unauthorized access and subsequent data exfiltration.